DK191991A - Immunologisk aktive peptider, der er i stand til at fremkalde immunisering mod malaria, og gener, der koder derfor - Google Patents

Immunologisk aktive peptider, der er i stand til at fremkalde immunisering mod malaria, og gener, der koder derfor Download PDF

Info

Publication number
DK191991A
DK191991A DK191991A DK191991A DK191991A DK 191991 A DK191991 A DK 191991A DK 191991 A DK191991 A DK 191991A DK 191991 A DK191991 A DK 191991A DK 191991 A DK191991 A DK 191991A
Authority
DK
Denmark
Prior art keywords
immunologically active
genes coding
active peptides
immunization against
against malaria
Prior art date
Application number
DK191991A
Other languages
English (en)
Other versions
DK166155B (da
DK166155C (da
DK191991D0 (da
Inventor
Thomas Frank Mccutchen
John Barton Dame
Jackie Lekster Williams
Imogene Schneider
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of DK191991A publication Critical patent/DK191991A/da
Publication of DK191991D0 publication Critical patent/DK191991D0/da
Publication of DK166155B publication Critical patent/DK166155B/da
Application granted granted Critical
Publication of DK166155C publication Critical patent/DK166155C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

Figure DK191991AD00021
DK191991A 1984-06-26 1991-11-26 Immunologisk aktive peptider, der er i stand til at fremkalde immunisering mod malaria, malariamodvirkende immunogent stimulerende middel indeholdende disse, anvendelse deraf til fremstilling af et malariaimmuniserende middel, en dna-sekvens, der koder for peptiderne, en dna-kloningsbaerer der omfatter dna-sekvensen samt en e. coli-organisme, der indeholder dna-sekvensen DK166155C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62456484 1984-06-26
US06/624,564 US4707357A (en) 1984-06-26 1984-06-26 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Publications (4)

Publication Number Publication Date
DK191991A true DK191991A (da) 1991-11-26
DK191991D0 DK191991D0 (da) 1991-11-26
DK166155B DK166155B (da) 1993-03-15
DK166155C DK166155C (da) 1993-08-09

Family

ID=24502471

Family Applications (2)

Application Number Title Priority Date Filing Date
DK289185A DK166284C (da) 1984-06-26 1985-06-26 Immunologisk aktivt peptid, der er i stand til at fremkalde immunisering mod malaria, malariamodvirkende immunogent stimulerende middel, der indeholder peptidet, anvendelse af peptidet til fremstilling af et saadant middel, en dna-sekvens, der koder for peptidet, en rekombinant dna-kloningsbaerer, der omfatter dna-sekvensen samt e. coli, der indeholder kloningsbaereren
DK191991A DK166155C (da) 1984-06-26 1991-11-26 Immunologisk aktive peptider, der er i stand til at fremkalde immunisering mod malaria, malariamodvirkende immunogent stimulerende middel indeholdende disse, anvendelse deraf til fremstilling af et malariaimmuniserende middel, en dna-sekvens, der koder for peptiderne, en dna-kloningsbaerer der omfatter dna-sekvensen samt en e. coli-organisme, der indeholder dna-sekvensen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK289185A DK166284C (da) 1984-06-26 1985-06-26 Immunologisk aktivt peptid, der er i stand til at fremkalde immunisering mod malaria, malariamodvirkende immunogent stimulerende middel, der indeholder peptidet, anvendelse af peptidet til fremstilling af et saadant middel, en dna-sekvens, der koder for peptidet, en rekombinant dna-kloningsbaerer, der omfatter dna-sekvensen samt e. coli, der indeholder kloningsbaereren

Country Status (9)

Country Link
US (1) US4707357A (da)
EP (1) EP0166410B1 (da)
JP (4) JP2561238B2 (da)
AU (1) AU596561B2 (da)
CA (1) CA1340431C (da)
DE (1) DE3586853T2 (da)
DK (2) DK166284C (da)
HK (1) HK1001823A1 (da)
ZA (1) ZA854697B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566780B1 (fr) * 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
ATE78869T1 (de) * 1985-02-07 1992-08-15 Smithkline Beecham Corp Malaria-impfstoff.
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
PT82282B (pt) * 1985-03-28 1988-02-17 Univ New York Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
AU590599B2 (en) * 1985-07-12 1989-11-09 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4957869A (en) * 1985-07-12 1990-09-18 New York University Immunogenic peptide corresponding to P. vivax CS protein
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
US5019384A (en) * 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
IT1196501B (it) * 1986-07-16 1988-11-16 Eniricerche Spa Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche
US5225530A (en) * 1986-07-16 1993-07-06 Eniricerche S.P.A. Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
US4957738A (en) * 1987-01-14 1990-09-18 Patarroyo Manuel E Protein copolymer malaria vaccine
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5273876A (en) * 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
EP0319570B1 (en) * 1987-06-26 1995-02-22 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene and use thereof
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
ATE139537T1 (de) * 1988-05-02 1996-07-15 Us Health Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff
US5028425A (en) * 1988-07-07 1991-07-02 The United States Of America As Represented By The Department Of Health And Human Services Synthetic vaccine against P. falciparum malaria
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
EP0409923A4 (en) * 1988-12-21 1993-01-20 Smithkline Biologicals Expression of the i(plasmodium) circumsporozoite protein in insect cells
EP0378881B1 (en) * 1989-01-17 1993-06-09 ENIRICERCHE S.p.A. Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
CA2031197A1 (en) * 1989-04-12 1990-10-13 James P. Tam Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
NZ233494A (en) * 1989-05-03 1993-08-26 Smithkline Beecham Corp Polypeptides comprising plasmodium surface protein with a reduced number of repeating immunogenic determinants fused to a carrier protein; vectors coding therefor and vaccines
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens
US5695957A (en) * 1990-02-05 1997-12-09 Imperial Exploitation Limited Polypeptides and DNA encoding same, associated with human malaria parasites
JPH05501112A (ja) * 1990-02-22 1993-03-04 アメリカ合衆国 プラスモヂウムの抗原タンパク質
GB9015888D0 (en) * 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
US6566121B1 (en) 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
NO986133D0 (no) * 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033776A1 (de) * 1980-09-09 1982-04-22 Behringwerke Ag, 3550 Marburg Verfahren zur vermehrung von protozoen
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
ATE78869T1 (de) * 1985-02-07 1992-08-15 Smithkline Beecham Corp Malaria-impfstoff.

Also Published As

Publication number Publication date
DK166284B (da) 1993-03-29
DK289185D0 (da) 1985-06-26
DK166155B (da) 1993-03-15
HK1001823A1 (en) 1998-07-10
DE3586853T2 (de) 1993-10-07
AU596561B2 (en) 1990-05-10
JPH07110876B2 (ja) 1995-11-29
JP2537027B2 (ja) 1996-09-25
DK289185A (da) 1985-12-27
EP0166410A3 (en) 1987-11-25
AU4399085A (en) 1986-01-02
JPS61149093A (ja) 1986-07-07
US4707357A (en) 1987-11-17
DE3586853D1 (de) 1993-01-07
DK166155C (da) 1993-08-09
JPH06225768A (ja) 1994-08-16
ZA854697B (en) 1986-02-26
JP2561238B2 (ja) 1996-12-04
DK166284C (da) 1993-08-23
JP2537028B2 (ja) 1996-09-25
EP0166410A2 (en) 1986-01-02
EP0166410B1 (en) 1992-11-25
JPH07265087A (ja) 1995-10-17
DK191991D0 (da) 1991-11-26
CA1340431C (en) 1999-03-16
JPH07265086A (ja) 1995-10-17

Similar Documents

Publication Publication Date Title
DK191991A (da) Immunologisk aktive peptider, der er i stand til at fremkalde immunisering mod malaria, og gener, der koder derfor
FR2601370B1 (fr) Vaccin contre le melanome.
IT8224948A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.
DE3786767T3 (de) Neues Polypeptid.
IT8421518A0 (it) Perfezionata, particolarmente per piattaforma di supporto un motore e relativo dispositivo condotto.
DK188686A (da) Vindmaelle
NO874159D0 (no) Nye lymfokin-relaterte peptider.
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
DE68921923D1 (de) Rekombinante Coccidiosis-Vakzine.
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DK284874A (da) 1,3-oxazino (5,6-c)rifamyciner og fremgangsmade til fremstilling deraf
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
DE3781770D1 (de) Schnellen druck aufbauende tauchkolbenpumpe.
DE68918712D1 (de) Rekombinante Eimeria tenella-Vakzine.
DE3382718D1 (de) Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
DK258185A (da) Peptid og gen, der koder derfor
DE3586765D1 (de) Immunogenische hav-peptide.
DK282384A (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
IT1212790B (it) Peptidi biologicamente attivi.
IT1214444B (it) Peptidi biologicamente attivi.
OA08478A (fr) Vaccin contre la mélanome.
IT8719467A0 (it) Dispositivo di pompaggio dicombustibile.
IT8521535A0 (it) Dispositivo di pompaggio dicombustibile.
IT8121366V0 (it) Lumino, particolarmente per cimiteri.
IT8321041A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.

Legal Events

Date Code Title Description
PUP Patent expired